Prostate cancer is the most common cancer among men in 112 countries worldwide. However, if prostate cancer is detected early enough, the chances of recovery are very high. This requires that the disease be detected early enough using meaningful biomarkers. Dr. Maximilian Lindholz and Dr. Charlie…
The liver plays a central role in the body’s metabolism and immune regulation. Yet, many cellular mechanisms involved in liver diseases remain only partially understood. Researchers from Charité, Si-M – The Simulated Human and the Cincinnati Children’s Hospital Medical Center have now gained crucial…
In a study published at the end of August in the journal Molecular Therapy, Michael Kaminski, Verena Klämbt, and Matteus Krappitz – all participants of the BIH Charité Clinician Scientist Program – report an advancement in the fight against autosomal dominant polycystic kidney disease (ADPKD). The…
Digitalisation can fundamentally change healthcare: faster processes, better data availability and more time for patients. But despite the technical possibilities, there are obstacles that slow down progress. How can digitalisation be designed in such a way that it does not remain a technological…
Age is a critical factor for the severity and progression of COVID-19. However, the precise molecular and cellular mechanisms remain largely unclear to this day. Scientists at the Berlin Institute of Health in the Charité (BIH) and Charité – Universitätsmedizin Berlin have conducted a comprehensive…
The Forum Gesundheitsforschung makes 21 recommendations for the promotion of academic spin-offs. The aim is to bring biomedical innovations to patient care as quickly as possible (german-language).
Researchers from the Berlin Institute of Health at Charité (BIH) and the Max Planck Institute for Molecular Genetics, in collaboration with international colleagues, published a paper in Nature Genetics on a method to detect evolutionary conserved enhancers that diverged so much that their DNA…
Do you have an innovative idea or questions concerning IP and patents? The Idea Office is a service offered by Charité BIH Innovation, the joint technology transfer of Charité and the Berlin Institute of Health (BIH). It has been organized by Bettina Otto and Thomas Marek Wallach since 2022 and was…
BIH researchers and colleagues showed that public large-language models, such as DeepSeek, perform as well as proprietary models (e.g. GPT4o) that cannot be used for patient data. They can therefore be used for clinical decisions in routine care.
